select a format

Single User License
USD 5995 INR 384399
Site License
USD 11990 INR 768799
Corporate User License
USD 17985 INR 1153198

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


North America Glucose Monitoring Market Outlook to 2022

North America Glucose Monitoring Market Outlook to 2022


  • Products Id :- GDMECR0557DB
  • |
  • Pages: 160
  • |
  • January 2017
  • |
  • |
  Request for Sample Report

Executive Summary

North America Glucose Monitoring Market Outlook to 2022

Summary

GlobalData's new report, "North America Glucose Monitoring Market Outlook to 2022", provides key market data on the North America Glucose Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Blood Glucose Meters, Blood Glucose Test Strips and Lancets.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Glucose Monitoring market segments-Blood Glucose Meters, Blood Glucose Test Strips and Lancets.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the North America Glucose Monitoring market.

Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and Others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Vision Care Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Glucose Monitoring Market, North America 11

3.1 Glucose Monitoring Market, North America, Revenue ($m), 2008-2022 11

3.2 Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), 2008-2022 13

3.3 Glucose Monitoring Market, North America, Revenue ($m), 2008-2015 14

3.4 Glucose Monitoring Market, North America, Revenue ($m), 2015-2022 16

3.5 Glucose Monitoring Market, North America, Volume (Units), 2008-2022 18

3.6 Glucose Monitoring Market, North America, Volume (Units), 2008-2015 20

3.7 Glucose Monitoring Market, North America, Volume (Units), 2015-2022 22

3.8 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2015 24

4 Glucose Monitoring Market, Canada 26

4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2008-2015 26

4.2 Glucose Monitoring Market, Canada, Revenue ($m), 2015-2022 28

4.2.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2008-2015 30

4.2.2 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2015-2022 32

4.3 Glucose Monitoring Market, Canada, Volume (Units), 2008-2015 34

4.4 Glucose Monitoring Market, Canada, Volume (Units), 2015-2022 36

4.4.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2008-2015 38

4.4.2 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2015-2022 40

4.5 Glucose Monitoring Market, Canada, Average Price ($), 2008-2022 42

4.6 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2014-2015 43

4.7 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2015 44

5 Glucose Monitoring Market, Mexico 46

5.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2008-2015 46

5.2 Glucose Monitoring Market, Mexico, Revenue ($m), 2015-2022 48

5.2.1 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2008-2015 50

5.2.2 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2015-2022 52

5.3 Glucose Monitoring Market, Mexico, Volume (Units), 2008-2015 54

5.4 Glucose Monitoring Market, Mexico, Volume (Units), 2015-2022 56

5.4.1 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2008-2015 58

5.4.2 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2015-2022 60

5.5 Glucose Monitoring Market, Mexico, Average Price ($), 2008-2022 62

5.6 Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), 2014-2015 63

5.7 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2015 64

6 Glucose Monitoring Market, United States 66

6.1 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015 66

6.2 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022 68

6.2.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2008-2015 70

6.2.2 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2022 72

6.3 Glucose Monitoring Market, United States, Volume (Units), 2008-2015 74

6.4 Glucose Monitoring Market, United States, Volume (Units), 2015-2022 76

6.4.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2008-2015 78

6.4.2 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2022 80

6.5 Glucose Monitoring Market, United States, Average Price ($), 2008-2022 82

6.6 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015 83

6.7 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015 84

7 Overview of Key Companies in North America Glucose Monitoring Market 86

7.1 LifeScan Inc 86

7.1.1 Company Overview 86

7.2 Bayer HealthCare AG 86

7.2.1 Company Overview 86

7.3 Abbott Laboratories 86

7.3.1 Company Overview 86

7.4 F. Hoffmann-La Roche Ltd 87

7.4.1 Company Overview 87

7.5 DexCom Inc 87

7.5.1 Company Overview 87

7.6 Medtronic plc 87

7.6.1 Company Overview 87

7.7 Arkray Inc 87

7.7.1 Company Overview 87

7.8 Becton Dickinson and Co 88

7.8.1 Company Overview 88

7.9 Trividia Health Inc 88

7.9.1 Company Overview 88

8 Glucose Monitoring Market Pipeline Products 89

9 Recent Developments 91

9.1 Corporate Communications 91

9.1.1 Sep 20, 2016: Livongo Health Lands Dave Engberg from Evernote as Chief Technology Officer 91

9.1.2 Aug 16, 2016: One Drop Expands Diabetes Health and Behavioral Informatics Team With Addition of Chandra Osborn PhD, MPH as Vice President 91

9.1.3 Aug 02, 2016: PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. to its Board of Advisors 92

9.1.4 Aug 01, 2016: Zynerba Pharmaceuticals Announces Dosing of First Patients in Phase 2 STAR 1 Clinical Study of ZYN002 CBD Gel in Adult Epilepsy Patients with Refractory Focal Seizures 93

9.1.5 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 94

9.1.6 Jun 28, 2016: WellDoc, a Digital Health Technology Leader, Expands Leadership Team with Roster of Seasoned Healthcare Executives 95

9.1.7 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 96

9.1.8 Mar 23, 2016: GlucoTrack Maker Names Two New Board Members 97

9.1.9 Mar 15, 2016: M Pharmaceutical Announces Change to Management 97

9.1.10 Feb 26, 2016: Clinical Update On Thetanix For The Treatment Of Paediatric Crohn Disease : 4D Pharma 97

9.1.11 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 98

9.1.12 Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace 99

9.1.13 Jan 08, 2016: BioGaia's subsidiary IBT has US IND open and Swedish CTA approved for clinical study 100

9.2 Financial Announcements 101

9.2.1 Nov 21, 2016: PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015 101

9.2.2 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 102

9.2.3 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 102

9.2.4 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 104

9.2.5 Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 105

9.2.6 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 106

9.2.7 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 108

9.2.8 Sep 27, 2016: PositiveID Announces Highlights for Third Quarter 2016 110

9.2.9 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 111

9.2.10 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 111

9.2.11 Aug 15, 2016: PositiveID Reports Q2 2016 Revenue of $1.8 Million, Up from $51 Thousand in Q2 2015 112

9.2.12 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 113

9.2.13 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 115

9.2.14 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 116

9.2.15 Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 117

9.2.16 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results 118

9.2.17 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 119

9.2.18 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016 121

9.2.19 Jun 06, 2016: Sangui BioTech: Third Quarter Report 122

9.2.20 Jun 02, 2016: Fuel3D announces first enterprise client scanning solution 123

9.2.21 May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015 124

9.2.22 May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter 124

9.2.23 Apr 27, 2016: DexCom Reports First Quarter 2016 Financial Results 126

9.2.24 Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results 127

9.2.25 Apr 11, 2016: SteadyMed Announces Initiation Of Inter Partes Review Proceedings By U.S. Patent And Trademark Office Against A United Therapeutics Patent 128

9.2.26 Mar 10, 2016: Immunotherapeutic Potential of Manocept Platform Reviewed in the Journal Nuclear Medicine and Biology 130

9.2.27 Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results 132

9.2.28 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 133

9.2.29 Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results 134

9.3 Legal And Regulatory 137

9.3.1 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 137

9.3.2 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 137

9.3.3 Aug 10, 2016: CDC Exercises Contract Option Valued at $11.6 Million to Further Support Emergent BioSolutions' Vaccinia Immune Globulin 137

9.3.4 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 138

9.3.5 Mar 21, 2016: LifeWatch: Supplemental information on Highmark arbitration case 139

9.3.6 Mar 17, 2016: LifeWatch announces arbitration decision in Highmark case 140

9.3.7 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 140

9.3.8 Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer 140

9.4 Other Significant Developments 141

9.4.1 Dec 14, 2016: One Drop Announces Inaugural Members Of One Drop | Experts Advisory Board 141

9.4.2 Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes 143

9.4.3 Aug 17, 2016: Livongo for Diabetes Program Generates Positive Clinical, Financial Outcomes 144

9.4.4 Jun 21, 2016: PositiveID's Mobile Lab Business Completed 80 Projects in the First Half of 2016 145

9.4.5 May 17, 2016: Protagonist Therapeutics to Present New Data on PTG-200 at Digestive Disease Week 2016 145

9.4.6 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility 146

9.4.7 May 03, 2016: Sentnyl Therapeutics, Re-Launches Abstral in the United States 147

9.4.8 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 147

9.5 Product News 147

9.5.1 Sep 12, 2016: Indiana University Research and Technology issued record 53 U.S. patents in 2015-16 147

9.5.2 Jun 28, 2016: Trividia Health Initiates Voluntary Recall of Certain Lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood glucose test strip 149

9.5.3 Apr 26, 2016: New Vigilant Diabetes Management Companion Launched in U.S. That Alerts Users to Risk of Severe Hypoglycemia in Next 24 Hours 150

9.5.4 Mar 09, 2016: Dexcom continuous glucose monitor receivers 151

9.6 Strategy And Business Planning 151

9.6.1 Nov 22, 2016: Highly Pathogenic Bird Flu Spreading Across Europe and Asia; BiondVax's Universal Flu Vaccine Candidate Also Covers these Potential Pandemic Strains 151

9.6.2 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 152

9.6.3 Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona 153

9.6.4 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 154

9.6.5 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 154

10 Appendix 156

10.1 Research Methodology 157

10.1.1 Coverage 157

10.1.2 Secondary Research 157

10.1.3 Primary Research 158

10.1.4 Company Share Analysis 158

10.1.5 Distribution Share Analysis 158

10.1.6 Benchmarking 159

10.2 GlobalData Consulting 159

10.3 Contact Us 159

10.4 Disclaimer 160

1.2 List of Figures

Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 11

Figure 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 13

Figure 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 14

Figure 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 16

Figure 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022 18

Figure 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015 20

Figure 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022 22

Figure 8: Glucose Monitoring Market, North America, Company Share (%) 2015 24

Figure 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 26

Figure 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 28

Figure 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 30

Figure 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 32

Figure 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015 34

Figure 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022 36

Figure 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015 38

Figure 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022 40

Figure 17: Glucose Monitoring Market, Canada, Company Share (%) 2015 44

Figure 18: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 46

Figure 19: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 48

Figure 20: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 50

Figure 21: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 52

Figure 22: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015 54

Figure 23: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022 56

Figure 24: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015 58

Figure 25: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022 60

Figure 26: Glucose Monitoring Market, Mexico, Company Share (%) 2015 64

Figure 27: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 66

Figure 28: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 68

Figure 29: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 70

Figure 30: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 72

Figure 31: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 74

Figure 32: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 76

Figure 33: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 78

Figure 34: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 80

Figure 35: Glucose Monitoring Market, United States, Company Share (%) 2015 84

1.1 List of Tables

Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 12

Table 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 13

Table 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 15

Table 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 17

Table 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022 19

Table 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015 21

Table 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022 23

Table 8: Glucose Monitoring Market, North America, Company Share by Revenue ($m), USD Constant, 2015 25

Table 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 27

Table 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 29

Table 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 31

Table 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 33

Table 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015 35

Table 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022 37

Table 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015 39

Table 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022 41

Table 17: Glucose Monitoring Market, Canada, Average Price ($) Historic, 2008-2022 42

Table 18: Glucose Monitoring Market, Canada, Average Price ($), Forecast, 2015-2022 42

Table 19: Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43

Table 20: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 45

Table 21: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 47

Table 22: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 49

Table 23: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 51

Table 24: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 53

Table 25: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015 55

Table 26: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022 57

Table 27: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015 59

Table 28: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022 61

Table 29: Glucose Monitoring Market, Mexico, Average Price ($) Historic, 2008-2022 62

Table 30: Glucose Monitoring Market, Mexico, Average Price ($), Forecast, 2015-2022 62

Table 31: Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015 63

Table 32: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015 65

Table 33: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 67

Table 34: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 69

Table 35: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 71

Table 36: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 73

Table 37: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015 75

Table 38: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022 77

Table 39: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015 79

Table 40: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022 81

Table 41: Glucose Monitoring Market, United States, Average Price ($), Historic, 2008-2015 82

Table 42: Glucose Monitoring Market, United States, Average Price ($), Forecast, 2015-2022 82

Table 43: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 83

Table 44: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015 85

Table 45: Glucose Monitoring Market Pipeline Products 89

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

LifeScan Inc, Bayer HealthCare AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, DexCom Inc, Medtronic plc, Arkray Inc, Becton Dickinson and Co, Trividia Health Inc

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com